Cargando…
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
BACKGROUND: Lipoprotein-associated phospholipase A(2 )(Lp-PLA(2)) is a recently identified and potentially useful plasma biomarker for cardiovascular and atherosclerotic diseases. However, the correlation between the Lp-PLA(2 )activity and carotid atherosclerosis remains poorly investigated in patie...
Autores principales: | Gong, Hui-ping, Du, Yi-meng, Zhong, Li-na, Dong, Zhao-qiang, Wang, Xin, Mao, Yong-jun, Lu, Qing-hua |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031256/ https://www.ncbi.nlm.nih.gov/pubmed/21247435 http://dx.doi.org/10.1186/1476-511X-10-13 |
Ejemplares similares
-
Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome
por: Cremonini, Anna Laura, et al.
Publicado: (2022) -
Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021) -
Association between high‐sensitivity C‐reactive protein, lipoprotein‐associated phospholipase A2 and carotid atherosclerosis: A cross‐sectional study
por: Liu, Huamin, et al.
Publicado: (2018) -
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016) -
Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)